250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science Angel Investors in July 2025

A list of 50 angel investors that invest in Life science startups. We rank investors based on the number of investments they made in Life science companies. This investor list updates every month.

Top 50 Life Science Angel Investors in July 2025

Investor Life Science investments
Jonathan Milner 11
Jeff Dean 5
Sahin Boydas 5
Milad Alucozai 5
Nadav Rosenberg 4
bumpkins profile 4
Stefano Bernardi 3
Andrew Nutter 3
Esther Dyson 3
Jude Gomila 3
Andrew Keys 3
Bradley Horowitz 3
Ian Hogarth 3
Balaji Srinivasan 3
Mei Z. 3
Kevin Moore 3
Darian Shirazi 3
Elad Gil 3
Chris Gibson 3
Erik Peterson 3
Nico Wittenborn 2
Peter Harris 2
Sridhar Iyengar 2
Kathryn Haun 2
Zach Weinberg 2
Patrick Collison 2
Jay Zaveri 2
Carsten Maschmeyer 2
Nicholas Edwards 2
Joe Betts-Lacroix 2
Ed Parkinson 2
Alec Nielsen 2
Darrin Disley 2
Craig Mundie 2
Michael Chambers 2
Mark Evans 2
Aidan Gomez 2
Nat Turner 2
Thor Bjorgolfsson 2
Joshua Elkington 2
Annie Vereecken 2
Kevin Mahaffey 2
Robert Kopple 2
Albert Wenger 2
CJ Reim 2
Lars Fjeldsoe-Nielsen 2
Luc Vauterin 2
Jon Oringer 2
Avichal Garg 2
Sauli Törmälä 2
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 11 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Spain
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different now.
Jeff Dean Angel · Palo Alto, California, United States · 24 investments in the past 12 months
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more
Investment focus
  • Artificial Intelligence, Information Technology, Software
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Japan
Portfolio highlights
  • Akido Labs — At Akido, we collaborate with healthcare, government, and non-profit institutions to implement programs that tackle inequities in public health.
  • Emerald AI — Emerald AI creates a platform that enables AI data centers to adjust power consumption from electricity grids dynamically. This system orchestrates computing loads across data centers to bolster grid reliability. The technology aims to advance AI innovation while ensuring power affordability and electric system stability.
  • Parallel Bio — Using the immune system to cure disease. Parallel Bio uses a human immune system in a dish and AI to discover drugs more likely to work in patients.
Sahin Boydas Angel · San Francisco Bay Area, California, United States · 18 investments in the past 12 months
Sahin Boydas is the founder of Stealth AI Startup. He previously served as the Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He attended Koç University.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Seed, Series A, Series B
  • United States, Mexico, Spain
Portfolio highlights
  • CapStack Technologies — Discover Capstack, the leading bank-to-bank marketplace driving banking digital transformation. Join the innovation wave and transform your banking experience now!
  • Sully.ai — Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs)
  • Pallet — Pallet is a all-in-one logistics solution that integrates a Transportation Management System (TMS) and Warehouse Management System (WMS), to billing and reporting. Schedule a demo to see the future of modern freight businesses.
Milad Alucozai Angel · San Francisco, California, United States
Dr. Milad Alucozai specializes in translating scientific and technological breakthroughs into scalable commercial ventures. As an Afghan-American neuroscientist, entrepreneur, and global investor, he leverages his expertise in bioengineering, computational biology, and machine learning to identify promising innovations and develop strategies fortheir successful market entry and growth. He focuses on accelerating the process of bringing groundbreaking discoveries from the lab to market, particularly in the life sciences and computationally-driven fields.Dr. Alucozai is a co-founder of Revalia Bio, which aims to create a human-centric infrastructure for drug discovery and development. By utilizing non-transplantable human organs donated for research, Revalia provides the scientific community unparalleled insights into patient biology, ultimately aiding in the development of better treatments and cures. In 2024, he partnered with The Wyss Institute at Harvard University to launch and co-host the popular "Code to Cure" series, exploring the convergence of AI, biology, and healthcare. He also contributes his expertise as a Senior Fellow in Healthcare Engineering at the Regenstrief Center.His background includes leading 70 early-stage investments as Head of Bio and Deep Tech at BoxOne Ventures, establishing the firm as a key player in North America's VC landscape. He also served as a Venture Partner at Entrepreneur First, a globally recognized talent investor backed by notable figures like Patrick and John Collison of Stripe and Reid Hoffman of LinkedIn, with a portfolio exceeding $10 billion in value. He mentors entrepreneurs across North America and Europe through channels like the Creative Destruction Lab.Throughout his operating and investing career, he has been instrumental in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. Often serving as the first investor, he guides companies from concept to successful exit and shapes business development for high-growth, venture-backed startups. His advisory work also extends to established corporations; at Accenture, he led teams advising top pharmaceutical companies on their R&D, innovation, and business development strategies. In 2020, he formally served as an External Advisor to AstraZeneca.He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a Neuroscience degree from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a visiting scholarship at the Wyss Institute at Harvard University.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Nadav Rosenberg Angel · London, England, United Kingdom
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • United Kingdom, France, Israel
Portfolio highlights
  • thymia — Making mental health as objectively measurable as physical health.
  • Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way
  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
bumpkins profile Angel
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, India
Portfolio highlights
  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Stefano Bernardi Angel · San Francisco, California, United States
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more
Investment focus
  • Biotechnology, Software, Artificial Intelligence
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, Italy, France
Portfolio highlights
  • Freatic — Building the monetization layer for your alpha
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Andrew Nutter Angel · Paris, Ile-de-France, France
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Pre-Seed, Funding Round
  • France, United Kingdom, United States
Portfolio highlights
  • Yavin — Yavin provides modern point-of-sale solutions for European merchants
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Esther Dyson Angel · New York, New York, United States
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Funding Round
  • United States, Canada, Russian Federation
Portfolio highlights
  • Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
  • Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Jude Gomila Angel · San Francisco, California, United States
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada
Portfolio highlights
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Andrew Keys Angel
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more
Investment focus
  • Software, Finance, Blockchain
  • Seed, Pre-Seed, Series A
  • United States, India, Norway
Portfolio highlights
  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Bradley Horowitz Angel · Palo Alto, California, United States · 4 investments in the past 12 months
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • /dev/agents — /dev/agents platform will work on new UI patterns that make it easier to build AI agents in a new cloud-based operating system.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
Ian Hogarth Angel · London, England, United Kingdom
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Germany
Portfolio highlights
  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.
Balaji Srinivasan Angel · San Francisco Bay Area, California, United States · 21 investments in the past 12 months
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more
Investment focus
  • Blockchain, Cryptocurrency, Software
  • Seed, Pre-Seed, Series A
  • United States, India, Singapore
Portfolio highlights
  • Aspora — Aspora help users bank seamlessly across countries, invest in diverse assets, access credit and insurance services.
  • Kindly MD — Kindly MD is a healthcare services and technology company that offers solutions for sleep support, pain treatment, and medication management through advanced data analytics. The company integrates mental health services, traditional medication, and plant-based alternatives to provide comprehensive, whole-person treatment. Dedicated to promoting abrighter, healthier future, Kindly MD delivers personalized care that addresses the unique needs of each patient.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
Mei Z. Angel · San Francisco Bay Area, California, United States · 4 investments in the past 12 months
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more
Investment focus
  • Software, Artificial Intelligence, Biotechnology
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Singapore
Portfolio highlights
  • FlyMy.AI — Access cutting-edge media AI instantly. Stable, scalable, fast.
  • WilsonAI — WilsonAI makes the world's best AI paralegal for company's legal teams. It acts as an intelligent legal front door and assists with automating workflows while maintaining oversight.
  • BenchFlow — Largest benchmark hub
Kevin Moore Angel · Dallas, Texas, United States
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Pre-Seed, Angel
  • United States, India, Canada
Portfolio highlights
  • Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Augmend — Create documentation and an AI assistant from any video.
Darian Shirazi Angel · San Francisco, California, United States · 13 investments in the past 12 months
Darian Shirazi is the Managing Partner of Gradient.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
  • Twenty (YC S23) — Building a better Salesforce, powered by the Open Source community.
  • Twenty — Twenty builds the modern salesforce, powered by the open source community.
Elad Gil Angel · San Francisco, California, United States · 20 investments in the past 12 months
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, United Kingdom, Israel
Portfolio highlights
  • Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
  • Harvey — Harvey is an artificial intelligence technology service provider.
  • Applied Intuition — Applied Intuition enables engineering and product development teams to safely develop, test, and deploy autonomous vehicles at scale.
Chris Gibson Angel · Salt Lake City, Utah, United States
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Seed
  • United States, France, Switzerland
Portfolio highlights
  • Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Erik Peterson Angel · Chicago, Illinois, United States
Erik Peterson is the Founder at DormTrader.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Equity Crowdfunding, Series A
  • United States, Canada, Algeria
Portfolio highlights
  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Nico Wittenborn Angel · New York, New York, United States
Nico Wittenborn is an Investor at Adjacent.
Show more
Investment focus
  • Software, Health Care, Mobile Apps
  • Seed, Series A, Series B
  • United States, Germany, France
Portfolio highlights
  • Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Peter Harris Angel
Peter Harris
Show more
Investment focus
  • Life Science, Biotechnology, Health Diagnostics
  • Seed
  • United States
Portfolio highlights
  • CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
Sridhar Iyengar Angel · Burlingame, California, United States
A serial entrepreneur in connected medical devices and wearables, Sridhar is focused on strategy and management at Elemental Machines. Previously, Sridhar was a founder and director of Misfit, makers of elegant wearable products, which was acquired by Fossil in 2015. Prior to Misfit, he founded AgaMatrix, a blood glucose monitoring company thatmade the world’s first medical device connecting directly to the iPhone. AgaMatrix shipped 15+ FDA-cleared medical products, 2B+ biosensors, 6M+ glucose meters, with partnerships with Apple, Sanofi, and Walgreens. Sridhar holds over 30 US and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar. Beyond Elemental Machines, Sridhar has been known to run 13.1 miles on occasion and has sometimes been spotted on stage behind a wall of drums.
Show more
Investment focus
  • B2B, Life Science, Information Technology
  • Seed, Angel, Series A
  • United States
Portfolio highlights
  • Stedi — Automate healthcare transactions like real-time eligibility checks and claims processing with APIs that support thousands of payers.
  • Fuel — Slot Online Dan Judi Bola, Pkv QQ Poker Terpercaya
  • Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
Kathryn Haun Angel · San Francisco, California, United States
Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.
Show more
Investment focus
  • Blockchain, Financial Services, FinTech
  • Funding Round, Seed, Series A
  • United States, United Kingdom
Portfolio highlights
  • dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
  • Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
  • Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
Zach Weinberg Angel · New York, New York, United States
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more
Investment focus
  • Health Care, Software, SaaS
  • Seed, Series A, Pre-Seed
  • United States, Israel, United Kingdom
Portfolio highlights
  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Crosby — Crosby is a company with programmers from Ramp, Vanta, Meta, and Google joining attorneys.
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Patrick Collison Angel · San Francisco, California, United States · 4 investments in the past 12 months
Patrick Collison is the Co-Founder, CEO and Content Strategist of Stripe. He previously worked at Auctomatic as a Co-Founder. Patrick Collison attended Massachusetts Institute of Technology.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Series A, Seed, Series C
  • United States, United Kingdom, India
Portfolio highlights
  • Cortex — Cortex makes it easy for engineering organizations to gain visibility into their services and deliver high quality software.
  • Cursor — Cursor is an AI code editor used to enhance software engineering productivity. It offers a platform allowing developers to write code using predictive typing and natural language instructions. It also integrates with their existing codebase, ensuring privacy and security with SOC 2 certification.
  • Pacific Fusion — Pacific Fusion was founded in 2023 with the mission to power the world with abundant, affordable, clean energy.
Jay Zaveri Angel · San Francisco Bay Area, California, United States
Jay Zaveri has been serving Social Capital as a partner since November 2015. He also founded CloudOn and Future Thought Productions.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United States, Japan, Canada
Portfolio highlights
  • Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
  • BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
  • Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Carsten Maschmeyer Angel · Hanover, Niedersachsen, Germany
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Angel, Series A
  • Germany, Austria, Switzerland
Portfolio highlights
  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • theblood — We are giving back self-determination, control and specific health conditions to our users through a non-invasive menstrual blood test
  • JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
Nicholas Edwards Angel · Oxford, Oxfordshire, United Kingdom
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Joe Betts-Lacroix Angel · San Francisco Bay Area, California, United States
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more
Investment focus
  • Life Science, Biotechnology, Pharmaceutical
  • Seed
  • United States
Portfolio highlights
  • VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
  • Spring Discovery — Giving Scientists AI Superpowers
Ed Parkinson Angel
Ed Parkinson
Show more
Investment focus
  • Software, Health Care, Life Science
  • Seed
  • United Kingdom
Portfolio highlights
  • Antiverse — Designing biologics for 100 challenging targets
Alec Nielsen Angel · Cambridge, Massachusetts, United States
Alec Nielsen is the Founder & CEO at Asimov.
Show more
Investment focus
  • Biotechnology, Robotics, Biopharma
  • Seed
  • United States
Portfolio highlights
  • LatchBio — The command center for all gene-editing bioinformatics. Analyze your CRISPR data without code in 5 minutes.
  • Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
  • Lamin — Lamin Labs provides data infrastructure for biology that enables data scientists and engineers to collaborate on a single data layer for R&D teams of any size. They want to achieve for R&D data what git and GitHub did for code by integrating wet and dry laboratories, people and AI, knowledge and data, and siloed teams and organizations.Lamin Labs is headquartered in Munich, Bayern and was founded in 2022.
Darrin Disley Angel · Cambridge, Cambridgeshire, United Kingdom
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more
Investment focus
  • Biotechnology, Health Care, Big Data
  • Seed, Series A, Funding Round
  • United Kingdom
Portfolio highlights
  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Craig Mundie Angel
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more
Investment focus
  • Life Science, Chemical, Genetics
  • Seed, Series B, Series C
  • United States
Portfolio highlights
  • Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
  • Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Michael Chambers Angel · Fargo, North Dakota, United States
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Series A, Funding Round
  • United States
Portfolio highlights
  • Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
  • Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Mark Evans Angel · London, England, United Kingdom
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Series A, Seed, Funding Round
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Aidan Gomez Angel · Oxford, Arkansas, United States · 2 investments in the past 12 months
Aidan Gomez is a Co-founder & CEO of Cohere. He attended University of Oxford.
Show more
Investment focus
  • Artificial Intelligence, Software, Information Technology
  • Seed, Pre-Seed
  • United States
Portfolio highlights
  • DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Nat Turner Angel · New York, New York, United States
Nat Turner is the Chairman and CEO of Collectors. He joins the Board of Directors at GameStop. Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time.Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerous internet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, China, Colombia
Portfolio highlights
  • CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
  • Collectors — Helping collectors to pursue their passion.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Thor Bjorgolfsson Angel · London, England, United Kingdom
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more
Investment focus
  • Big Data, TV, TV Production
  • Seed, Series A, Series C
  • United Kingdom, Germany
Portfolio highlights
  • Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • atai Life Sciences — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Joshua Elkington Angel
Joshua Elkington
Show more
Investment focus
  • Biopharma, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
  • Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Annie Vereecken Angel
Annie Vereecken
Show more
Investment focus
  • Biotechnology, Medical, Hospital
  • Seed, Series A, Funding Round
  • Belgium
Portfolio highlights
  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Kevin Mahaffey Angel · San Francisco, California, United States · 3 investments in the past 12 months
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more
Investment focus
  • Software, SaaS, Enterprise Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, Israel
Portfolio highlights
  • Karman+ — Mining near Earth asteroids
  • Knostic — Knostic provides need-to-know access controls for Large Language Models (LLMs). Its knowledge-centric capabilities enable enterprises to expedite the deployment of LLMs and drive AI-powered innovation while maintaining value, security, and safety.
  • Fleet Device Management — Open-source IT and security for teams with lots of workstations and servers. (Linux, macOS, Windows, cloud, data center, OT/ICS, Chrome)
Robert Kopple Angel · Los Angeles, California, United States
Robert Kopple
Show more
Investment focus
  • FinTech, Finance, Life Science
  • Funding Round, Convertible Note
  • United States, United Kingdom
Portfolio highlights
  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Albert Wenger Angel · New York, New York, United States
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more
Investment focus
  • Software, Analytics, Manufacturing
  • Series A, Series B, Seed
  • United States, Germany, Egypt
Portfolio highlights
  • Brale — Combining the best of CeFi & DeFi.
  • Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
  • Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
CJ Reim Angel · San Francisco, California, United States
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more
Investment focus
  • E-Commerce, Robotics, Software
  • Series A, Seed, Series D
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Lars Fjeldsoe-Nielsen Angel · London, England, United Kingdom
Lars Fjeldsoe-Nielsen is a Co-Founder & serves as a Partner at 2xN and General Partner at Owl Ventures. Lars Fjeldsoe-Nielsen was General Partner at Balderton Capital in London from 2015-2021 through four funds. He joined after spending a decade in Silicon Valley where he was with Uber and Dropbox.Since 2012 his venture track record includestwo IPOs (Uber, Dropbox) and 11 acquisitions.Lars joined Balderton from Uber which he joined when the company was operating in less than 20 cities. His role as Vice-President resulted in strategic alliances. Lars joined Uber from Dropbox as one of the company’s first 25 employees. As Head of Mobile, his growth deals with Samsung and other mobile OEMs helped Dropbox reach its first 100 million users. Prior to that Lars held positions at Voicesignal (acq. Nuance), Skyhook Wireless (acq. TruePosition), Ness Technologies (acq. Opentable), 3Jam (acq. Skype) and T9 Tegic (acq. AOL). More than a billion people have used the software and services distributed as a result of mobile growth partnerships led by Lars.His venture investments include Voi (Raine), Labster (A16Z), Hiya (Ericsson), Cambridge Quantum Computing (HON), Hopin (A16Z), Opensea (A16Z), Yassir (YC), Beacon (Eric Schmidt), The org (Sequoia), Octant (A16Z), Zycada (Khosla), Monarch Money (Accel) and Kukua (Tencent), Dubsmash (acq. Reddit), Tempow (acq. Google), Rahko (acq. Odyssey Therapeutics), Pocket (acq. Mozilla), Blue Bottle (acq. Nestle), Marble (acq. Caterpillar).Lars, who is Danish-Portuguese, grew up across Africa and served with the Royal Danish Guards. He holds a MBA from London Business School, where he also serves on the Board of Trustees, an MSc from Oxford University Keble College and a BSc from King’s College, London. He lives in London with his wife and three children.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Funding Round
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Blue — Coming Q3. Join the waitlist here.
  • Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
  • UrbanKisaan — UrbanKisaan builds vertical farms in India and sells the produce directly to consumers via subscription based app. The farms create a positive change at every step from seed to store ensuring quality and traceability. They grow fresh veggies locally produced which are grown without using soil using 95% less water. It aims to create a sustainablefuture for farming and feed the world in a way that is good for both people and the planet.It was founded in 2017 and is headquartered in Hyderabad, Andhra Pradesh, India.
Luc Vauterin Angel
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
  • Life Science, Data Integration, Data Visualization
  • Seed, Series A
  • Belgium
Portfolio highlights
  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Jon Oringer Angel · New York, New York, United States
Jon Oringer is the founder and chairman of Shutterstock.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Series A
  • United States, France, United Kingdom
Portfolio highlights
  • SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
  • Unsloth AI — Open source fine-tuning & reinforcment learning (RL) for Llama 4, DeepSeek-R1, Qwen3, Gemma 3 and Mistral LLMs! Beginner friendly.
Avichal Garg Angel · Stanford, California, United States · 2 investments in the past 12 months
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more
Investment focus
  • Software, Blockchain, Internet
  • Seed, Series A, Funding Round
  • United States, Canada, Mexico
Portfolio highlights
  • Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Matic — The world's most advanced floor cleaner. Your home's best helper.
  • Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Sauli Törmälä Angel · Helsinki, Southern Finland, Finland
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Finland
Portfolio highlights
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Investors by industry
Investors by country
Angel Investors in life science by country